154 related articles for article (PubMed ID: 12271157)
1. Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells.
Langford SD; Trent MB; Boor PJ
Cardiovasc Toxicol; 2002; 2(2):141-50. PubMed ID: 12271157
[TBL] [Abstract][Full Text] [Related]
2. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.
Langford SD; Trent MB; Balakumaran A; Boor PJ
Toxicol Appl Pharmacol; 1999 Mar; 155(3):237-44. PubMed ID: 10079209
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of semicarbazide and beta-aminopropionitrile on the arterial extracellular matrix in the Brown Norway rat.
Mercier N; Kakou A; Challande P; Lacolley P; Osborne-Pellegrin M
Toxicol Appl Pharmacol; 2009 Sep; 239(3):258-67. PubMed ID: 19524603
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
[TBL] [Abstract][Full Text] [Related]
5. Acrolein generation stimulates hypercontraction in isolated human blood vessels.
Conklin DJ; Bhatnagar A; Cowley HR; Johnson GH; Wiechmann RJ; Sayre LM; Trent MB; Boor PJ
Toxicol Appl Pharmacol; 2006 Dec; 217(3):277-88. PubMed ID: 17095030
[TBL] [Abstract][Full Text] [Related]
6. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
Conklin DJ; Trent MB; Boor PJ
Toxicology; 1999 Nov; 138(3):137-54. PubMed ID: 10593505
[TBL] [Abstract][Full Text] [Related]
7. Characterization of human serum and umbilical artery semicarbazide-sensitive amine oxidase (SSAO). Species heterogeneity and stereoisomeric specificity.
Yu PH; Zuo DM; Davis BA
Biochem Pharmacol; 1994 Mar; 47(6):1055-9. PubMed ID: 8147904
[TBL] [Abstract][Full Text] [Related]
8. Interaction of L-lysine and soluble elastin with the semicarbazide-sensitive amine oxidase in the context of its vascular-adhesion and tissue maturation functions.
Olivieri A; O'Sullivan J; Fortuny LR; Vives IL; Tipton KF
Biochim Biophys Acta; 2010 Apr; 1804(4):941-7. PubMed ID: 20079884
[TBL] [Abstract][Full Text] [Related]
9. Modifications of arterial phenotype in response to amine oxidase inhibition by semicarbazide.
Mercier N; El Hadri K; Osborne-Pellegrin M; Nehme J; Perret C; Labat C; Regnault V; Lamazière JM; Challande P; Lacolley P; Fève B
Hypertension; 2007 Jul; 50(1):234-41. PubMed ID: 17452500
[TBL] [Abstract][Full Text] [Related]
10. Studies on the behaviour of semicarbazide-sensitive amine oxidase in Sprague-Dawley rats treated with the monoamine oxidase inhibitor tranylcypromine.
Fitzgerald DH; Tipton KF; Lyles GA
J Neural Transm Suppl; 1998; 52():259-64. PubMed ID: 9564625
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits.
Wang SH; Yu TY; Hung CS; Yang CY; Lin MS; Su CY; Chen YL; Kao HL; Chuang LM; Tsai FC; Li HY
Sci Rep; 2018 Jun; 8(1):9249. PubMed ID: 29915377
[TBL] [Abstract][Full Text] [Related]
12. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects.
Lyles GA
Int J Biochem Cell Biol; 1996 Mar; 28(3):259-74. PubMed ID: 8920635
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tissue-bound semicarbazide-sensitive amine oxidase by two haloamines, 2-bromoethylamine and 3-bromopropylamine.
Kinemuchi H; Kobayashi N; Takahashi K; Takayanagi K; Arai Y; Tadano T; Kisara K; Oreland L
Arch Biochem Biophys; 2001 Jan; 385(1):154-61. PubMed ID: 11361012
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of semicarbazide-sensitive amine oxidase induces the phenotypic switch of smooth muscle cells and aggravates the development of atherosclerotic lesions.
Zhang M; Liu L; Zhi F; Niu P; Yang M; Zhu X; Diao Y; Li Y; Wang J; Zhao Y
Atherosclerosis; 2016 Jun; 249():76-82. PubMed ID: 27065245
[TBL] [Abstract][Full Text] [Related]
15. Prolonged treatment with aminoguanidine strongly inhibits adipocyte semicarbazide-sensitive amine oxidase and slightly reduces fat deposition in obese Zucker rats.
Prévot D; Soltesz Z; Abello V; Wanecq E; Valet P; Unzeta M; Carpéné C
Pharmacol Res; 2007 Jul; 56(1):70-9. PubMed ID: 17548204
[TBL] [Abstract][Full Text] [Related]
16. Semicarbazide-sensitive amine oxidase activity in rat aortic cultured smooth muscle cells.
Blicharski JR; Lyles GA
J Neural Transm Suppl; 1990; 32():337-9. PubMed ID: 2128506
[TBL] [Abstract][Full Text] [Related]
17. Evidence for existence of thyroid hormone inducible semicarbazide-sensitive amine oxidase (SSAO) in rat heart cytosol.
Obata T; Nakashima M
Indian Heart J; 2016; 68(2):225-30. PubMed ID: 27133345
[TBL] [Abstract][Full Text] [Related]
18. Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells.
Manasieva V; Thakur S; Lione LA; Patel J; Baydoun A; Skamarauskas J
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358914
[TBL] [Abstract][Full Text] [Related]
19. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
